Celltrion DiaTrust COVID-19 Ag Rapid Test, Reference No. CT-P60 D-2 02

FDA Device Recall #Z-0953-2022 — Class I — April 1, 2022

Recall Summary

Recall Number Z-0953-2022
Classification Class I — Serious risk
Date Initiated April 1, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CELLTRION USA INC
Location Jersey City, NJ
Product Type Devices
Quantity 12,632 kits

Product Description

Celltrion DiaTrust COVID-19 Ag Rapid Test, Reference No. CT-P60 D-2 02

Reason for Recall

Point of Care (PoC) rapid test products were distributed to customers who did not have a valid CLIA ID.

Distribution Pattern

US Nationwide distribution.

Lot / Code Information

All lots distributed to end users without valid CLIA ID UPC: 8 806121 763044 Distributed from December 2021 through February 2022.

Other Recalls from CELLTRION USA INC

Recall # Classification Product Date
Z-0731-2022 Class II Celltrion DiaTrust COVID-19 Ag Rapid Test, Refe... Feb 25, 2022
Z-0659-2022 Class I Celltrion DiaTrust COVID-19 Ag Rapid Test, Refe... Dec 28, 2021
Z-0680-2022 Class I Celltrion DiaTrust COVID-19 Ag Rapid Test, Refe... Dec 2, 2021
Z-0558-2022 Class II Celltrion DiaTrust COVID-19 Ag Rapid Test, REF ... Dec 1, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.